StockWatch
·
Biotechnology: Pharmaceutical Preparations
Business UpdateJun 12, 2026, 08:31 AM

Quantum Cyber Terminates ATM Facility After $15M Warrant Proceeds

AI Summary

Quantum Cyber N.V. announced the termination of its at-the-market (ATM) issuance sales agreement with Maxim Group LLC, effective June 7, 2026. This decision reflects the company's significantly strengthened financial position, bolstered by over $15 million in warrant exercise proceeds received in May 2026. Quantum Cyber is now debt-free with no exercisable warrants outstanding, and management believes its current cash position provides ample funding for its strategic objectives, including technology licensing, R&D expansion, and strategic acquisitions.

Key Highlights

  • Quantum Cyber terminated its at-the-market (ATM) issuance sales agreement with Maxim Group LLC.
  • The termination follows the receipt of over $15 million in warrant exercise proceeds in May 2026.
  • The company's capital structure is now debt-free.
  • There are no exercisable warrants outstanding.
  • Management believes existing cash provides sufficient runway for continued platform build-out and strategic activities.
  • Strategic pipeline includes manufacturing facility acquisition and patent prosecution.